Takeda Pharmaceutical Company Limited (4502.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.92T |
| Enterprise Value | 13.21T |
| P/E Ratio | 27.61 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 2.3 |
| Price/Book Ratio | 1.42 |
| Enterprise/Revenue | 3.19 |
| Enterprise/EBITDA | 11.33 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.08 |
| Operating Margin | 0.13 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 4.51T |
| Revenue/Share | 3,003.52 |
| Gross Profit | 2.3T |
| EBITDA | 1.34T |
| Net Income | 191.76B |
| Diluted EPS | 119.64 |
Balance Sheet
| Total Cash | 454.4B |
| Total Cash/Share | 290.8 |
| Total Debt | 4.58T |
| Total Debt/Equity | 0.62 |
| Current Ratio | 1.15 |
| Book Value Per Share | 4,746.76 |
Price History
| 52-Week Change | 60.02 |
| 52-Week High | 6,989 |
| 52-Week Low | 4,309 |
| Moving Average 50 Days | 6,047.6 |
| Moving Average 200 Days | 5,594.4 |
Statistics
| Average Volume | 4.45M |
| Shares Outstanding | 1.6B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 202 |
| Trailing Annual Dividend Yield | 2.99 |
| Payout Ratio | 0.82 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
